The global medical imaging industry is rapidly evolving with the increasing adoption of minimally invasive procedures, and interventional radiology (IR) is at the forefront of this transformation. As per Expert Market Research, the global interventional radiology market size reached approximately USD 24.20 billion in 2024. Driven by the growing preference for image-guided therapies and the rising prevalence of chronic conditions, the market is expected to grow at a CAGR of 6.70% from 2025 to 2034, reaching nearly USD 46.29 billion by 2034.

Global Interventional Radiology Market Size

Interventional radiology is a medical subspecialty that utilizes imaging techniques such as X-ray, CT, ultrasound, and MRI to perform targeted, minimally invasive procedures. According to Wikipedia, IR procedures are commonly used in diagnostics and treatments across cardiology, oncology, neurology, and other clinical areas. These techniques reduce the need for open surgery, lower hospital stays, and offer faster recovery, driving their widespread adoption.

Global Interventional Radiology Market Share

North America currently dominates the global interventional radiology market, attributed to the presence of advanced healthcare infrastructure, increasing incidence of lifestyle-related diseases, and favorable reimbursement policies. The United States represents the largest national market, thanks to early adoption of innovative IR technologies and strong investment in healthcare digitization.

Europe holds the second-largest share, led by Germany, France, and the UK, while the Asia Pacific region is poised for the fastest growth due to rising healthcare expenditures, technological penetration in India and China, and a growing elderly population base.

Segment-wise, MRI systems, angiography systems, and CT scanners are major contributors, with cardiology and oncology applications accounting for the highest usage rates.

Global Interventional Radiology Market Growth & Trends

Several factors are fueling the continued expansion of the interventional radiology market:

  • Rising Chronic Disease Burden: Growing cases of cancer, cardiovascular diseases, and kidney disorders are increasing demand for non-invasive diagnostics and treatments.

  • Shift Toward Minimally Invasive Procedures: IR techniques offer fewer complications, reduced hospital stay, and quicker patient recovery, making them increasingly preferred over traditional surgery.

  • Technological Advancements: Developments in AI-based imaging, robotic navigation systems, and 3D visualization are enhancing procedural accuracy and outcomes.

  • Tele-radiology and Digital Integration: The integration of cloud-based imaging solutions and remote diagnostics supports wider accessibility and efficient patient management.

Overall, industry growth is supported by a combination of clinical demand and technological innovation.

Global Interventional Radiology Market Case Studies & News

  • In 2023, Siemens Healthineers launched its ARTIS icono ceiling system, enhancing precision in image-guided interventions for neuro and cardiovascular procedures.

  • Canon Medical Systems introduced advanced ultrasound and CT-guided biopsy technologies aimed at reducing procedure time and improving safety.

  • Samsung Medison partnered with various healthcare providers across Asia to deploy its high-end diagnostic ultrasound systems for interventional radiology.

Real-world applications include image-guided tumor ablation, angioplasty, embolization, and thrombolysis, widely used in oncology and vascular surgery.

Global Interventional Radiology Market Analysis

The competitive landscape is highly dynamic, characterized by innovation, strategic partnerships, and M&A activity:

  • General Electric, Siemens Healthineers, and Philips are global leaders, continually investing in AI-driven imaging solutions and hybrid operating room technologies.

  • Emerging players from Asia, such as Shenzhen Mindray and Trivitron Healthcare, are expanding their global footprint through cost-effective and regionally adapted imaging solutions.

  • Regulatory factors, such as the FDA’s evolving guidelines on contrast agents and CE marking for EU-based product launches, play a critical role in shaping market accessibility.

Regional Highlights:

  • In North America, advanced product launches and favorable insurance reimbursement models are key drivers.

  • In Asia Pacific, governments are investing in radiology infrastructure and public-private partnerships to increase procedural access.

Global Interventional Radiology Market Segmentation

Market Breakup by Products

  • MRI Systems

  • CT Scanners

  • Ultrasound Imaging Systems

  • Angiography Systems

  • Biopsy Devices

  • Fluoroscopy Systems

  • Others

Market Breakup by Technology

  • Catheters

  • Stents

  • Inferior Vena Cava (IVC) Filters

  • Hemodynamic Flow Alteration Devices

  • Angioplasty Balloons

  • Thrombectomy Systems

  • Embolization Devices

  • Biopsy Needles

  • Accessories

  • Others

Market Breakup by Procedure

  • Angioplasty

  • Angiography

  • Embolization

  • Thrombolysis

  • Biopsy and Drainage

  • Vertebroplasty

  • Nephrostomy

  • Other Procedures

Market Breakup by Application

  • Cardiology

  • Urology and Nephrology

  • Oncology

  • Gastroenterology

  • Obstetrics

  • Others

Market Breakup by End User

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centres

  • Others

Market Breakup by Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

These segmentations highlight the vast and diversified applicability of IR across diseases, institutions, and technologies.

Global Interventional Radiology Market Key Players

Key companies operating in the global interventional radiology market include:

  • General Electric

  • Koninklijke Philips N.V.

  • Carestream Health

  • Hitachi, Ltd.

  • Hologic, Inc.

  • Shimadzu Corporation

  • Siemens Healthcare GmbH

  • Canon Medical Systems Corporation

  • Samsung Medison Co., Ltd.

  • Medtronic Plc

  • Agfa-Gevaert Group

  • Teleflex Incorporated

  • Analogic Corporation

  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

  • Trivitron Healthcare

  • Stryker Corporation

  • Olympus Corporation

  • Toshiba Medical Systems

These firms are spearheading innovation, expanding their diagnostic portfolios, and collaborating with hospitals and research institutions to stay ahead in this high-potential market.

The global interventional radiology market is undergoing a transformative phase, fueled by demand for precision-based, minimally invasive care across clinical areas. With the convergence of imaging advancements, aging populations, and disease prevalence, the market is poised for robust expansion. Industry stakeholders focusing on integrated imaging platforms, real-time procedural tools, and patient-specific diagnostics are set to lead the next wave of growth.

For more detailed market insights, competitive strategies, and regional data, consult the full report by Expert Market Research.

Find More Blog:

CDMO Market size

Pancreatic Cancer Drug Pipeline Analysis share

Breast Cancer Drug Pipeline Analysis growth